NGAL, KIM-1, and interleukin-18 concentrations were measured in 922 participants at baseline and 2–4 h after contrast injection and demonstrated no changes, even in patients who developed KDIGO AKI [116]. This evidence concerns the gene LCN2 and acute kidney injury.